215 related articles for article (PubMed ID: 21320123)
1. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C
Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123
[TBL] [Abstract][Full Text] [Related]
2. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
3. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
Front Immunol; 2018; 9():2360. PubMed ID: 30374356
[TBL] [Abstract][Full Text] [Related]
4. Evidence for NK cell subsets based on chemokine receptor expression.
Berahovich RD; Lai NL; Wei Z; Lanier LL; Schall TJ
J Immunol; 2006 Dec; 177(11):7833-40. PubMed ID: 17114454
[TBL] [Abstract][Full Text] [Related]
5. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
[TBL] [Abstract][Full Text] [Related]
6. The biology of human natural killer-cell subsets.
Cooper MA; Fehniger TA; Caligiuri MA
Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
8. Functional subsets of mouse natural killer cells.
Hayakawa Y; Huntington ND; Nutt SL; Smyth MJ
Immunol Rev; 2006 Dec; 214():47-55. PubMed ID: 17100875
[TBL] [Abstract][Full Text] [Related]
9. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
10. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
[TBL] [Abstract][Full Text] [Related]
12. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
[TBL] [Abstract][Full Text] [Related]
13. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
[TBL] [Abstract][Full Text] [Related]
14. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
[TBL] [Abstract][Full Text] [Related]
16. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of human CD56
Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L
Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523
[TBL] [Abstract][Full Text] [Related]
18. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.
Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O
PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis.
Albayrak N; Dirix V; Aerts L; Van Praet A; Godefroid A; Dauby N; Windey P; Muylle I; Mascart F; Corbière V
J Leukoc Biol; 2022 May; 111(5):1031-1042. PubMed ID: 34889470
[TBL] [Abstract][Full Text] [Related]
20. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
